Form SEC STAFF LETTER - SEC Staff Letter: REDACTED EXHIBIT
SEC Accession No. 9999999997-19-007750
Filing Date
2019-12-02
Accepted
2019-12-03 11:24:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REDACTED EXHIBIT 164228
  Complete submission text file 9999999997-19-007750.txt   227203
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SEC STAFF LETTER
SIC: 2834 Pharmaceutical Preparations